{"id":22172,"date":"2025-10-07T12:33:15","date_gmt":"2025-10-07T12:33:15","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=22172"},"modified":"2025-10-07T12:33:15","modified_gmt":"2025-10-07T12:33:15","slug":"eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/","title":{"rendered":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u8a8d\u77e5\u75c7\u6cbb\u7642\u85acLEQEMBI IQLIK\u3092\u767a\u8868"},"content":{"rendered":"<p>\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u793eLEQEMBI\u00ae IQLIK\u2122\uff08\u4e00\u822c\u540d\uff1alecanemab-irmb\uff09\u306f\u3001\u65e9\u671f\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u8a8d\u77e5\u75c7\uff08AD\uff09\u6cbb\u7642\u7528\u306e\u76ae\u4e0b\u6ce8\u5c04\u5264\u3067\u3059\u3002\u8efd\u5ea6\u8a8d\u77e5\u969c\u5bb3\uff08MCI\uff09\u304a\u3088\u3073\u8efd\u5ea6\u8a8d\u77e5\u75c7\u3092\u542b\u307f\u307e\u3059\u3002\u3053\u306e\u65b0\u3057\u3044\u9078\u629e\u80a2\u306f\u3001LEQEMBI\u306b\u3088\u308b1\u5e74\u534a\u306e\u70b9\u6ef4\u9759\u6ce8\u6cbb\u7642\u306e\u5f8c\u306b\u63d0\u4f9b\u3055\u308c\u307e\u3059\u3002\u60a3\u8005\u3055\u3093\u306f\u30014\u9031\u9593\u3054\u3068\u306e\u70b9\u6ef4\u9759\u6ce8\u3092\u7d99\u7d9a\u3059\u308b\u304b\u3001\u90311\u56de360mg\u306e\u76ae\u4e0b\u6ce8\u5c04\u306b\u5207\u308a\u66ff\u3048\u308b\u304b\u3092\u9078\u629e\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u5834\u5408\u3001LEQEMBI IQLIK\u81ea\u52d5\u6ce8\u5c04\u5668\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>\u30a8\u30fc\u30b6\u30a4\u3068 <a href=\"https:\/\/www.biogen.com\/\">\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3<\/a> \u306f\u3001\u6cbb\u7642\u4e2d\u306e\u60a3\u8005\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308b\u305f\u3081\u3001LEQEMBI Companion\u2122\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u3067\u306f\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u69d8\u3005\u306a\u30ea\u30bd\u30fc\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\uff1a<\/p>\n<ul>\n<li>\u770b\u8b77\u6559\u80b2\u8005\u306b\u3088\u308b\u6559\u80b2\u652f\u63f4<\/li>\n<li>\u30b1\u30a2\u30fb\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u305f\u3081\u306e\u30a6\u30a7\u30eb\u30ab\u30e0\u30fb\u30ad\u30c3\u30c8<\/li>\n<li>\u30e1\u30c7\u30a3\u30bb\u30fc\u30d5\u3068\u5171\u306b\u5275\u3089\u308c\u305f\u30c7\u30b8\u30bf\u30eb\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0<\/li>\n<\/ul>\n<p>\u3053\u308c\u3089\u306e\u30c4\u30fc\u30eb\u306f\u3001\u60a3\u8005\u3068\u305d\u306e\u5bb6\u65cf\u304c\u65c5\u3092\u30ca\u30d3\u30b2\u30fc\u30c8\u3059\u308b\u306e\u3092\u52a9\u3051\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u6ce8\u5c04\u3092\u8ffd\u8de1\u3059\u308b\u3053\u3068\u3067\u60a3\u8005\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u81ea\u5b85\u3067\u306e\u6295\u4e0e\u65b9\u6cd5\u3082\u6307\u5c0e\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u4fdd\u967a\u3084\u7d4c\u6e08\u7684\u652f\u63f4\u306b\u95a2\u3059\u308b\u30ac\u30a4\u30c0\u30f3\u30b9\u3082\u53d7\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u5bfe\u8c61\u3068\u306a\u308b\u60a3\u8005\u69d8\u306f\u3001\u30a8\u30fc\u30b6\u30a4\u306e\u60a3\u8005\u69d8\u652f\u63f4\u30d7\u30ed\u30b0\u30e9\u30e0\uff08PAP\uff09\u3092\u901a\u3058\u3066\u3001LEQEMBI\u3092\u7121\u6599\u3067\u53d7\u3051\u53d6\u308b\u3053\u3068\u3082\u3067\u304d\u307e\u3059\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/cm-plus-launches-pharmo-ai-for-pharma-research-support\/\" rel=\"bookmark\">CM\u30d7\u30e9\u30b9\u3001\u88fd\u85ac\u7814\u7a76\u652f\u63f4\u300cpharmo.AI\u300d\u3092\u63d0\u4f9b\u958b\u59cb<\/a><\/h4>\n<p>LEQEMBI IQLIK\u3092\u4f7f\u3048\u3070\u3001\u81ea\u5b85\u3067\u6cbb\u7642\u3092\u53d7\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u6642\u9593\u3092\u77ed\u7e2e\u3057\u3001\u8f38\u6db2\u30bb\u30f3\u30bf\u30fc\u306e\u5fc5\u8981\u6027\u3092\u6e1b\u3089\u3059\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u65b0\u305f\u306a\u60a3\u8005\u3055\u3093\u304c\u533b\u7642\u8cc7\u6e90\u3092\u5229\u7528\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u53ef\u80fd\u6027\u3082\u3042\u308a\u307e\u3059\u3002\u3053\u306e\u6cbb\u7642\u85ac\u306f\u3001\u30a2\u30df\u30ed\u30a4\u30c9\u30fb\u30d9\u30fc\u30bf\u539f\u7dda\u7dad\u3068\u30d7\u30e9\u30fc\u30af\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306f\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\uff08AD\uff09\u306e\u795e\u7d4c\u5909\u6027\u904e\u7a0b\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u62c5\u3044\u624b\u3067\u3059\u3002\u3053\u306e\u6cbb\u7642\u85ac\u306f\u3001\u6700\u521d\u306e1\u5e74\u534a\u306e\u70b9\u6ef4\u9759\u6ce8\u30b3\u30fc\u30b9\u306e\u5f8c\u3082\u52b9\u679c\u3092\u6301\u7d9a\u3055\u305b\u308b\u3053\u3068\u3067\u3001\u75c5\u6c17\u306e\u9032\u884c\u3092\u9045\u3089\u305b\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u3067\u306f\u3001\u30a2\u30df\u30ed\u30a4\u30c9\u6591\u3084\u30bf\u30a6\u306e\u3082\u3064\u308c\u304c\u84c4\u7a4d\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306f\u795e\u7d4c\u7d30\u80de\u306b\u640d\u50b7\u3092\u4e0e\u3048\u3001\u8a8d\u77e5\u6a5f\u80fd\u306e\u4f4e\u4e0b\u3092\u3082\u305f\u3089\u3057\u307e\u3059\u3002LEQEMBI\u306f\u4e21\u65b9\u306e\u75c5\u614b\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u306b\u3057\u3066\u3044\u307e\u3059\u3002LEQEMBI\u306e2\u3064\u306e\u4f5c\u7528\u3067\u3001\u8133\u306e\u51b4\u3048\u3092\u9577\u304f\u4fdd\u3061\u307e\u3057\u3087\u3046\u3002<\/p>\n<p>LEQEMBI\u306e\u9069\u5fdc\u306f\u3001MCI\u307e\u305f\u306f\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306b\u3088\u308b\u8efd\u5ea6\u8a8d\u77e5\u75c7\u3067\u3059\u3002 <a href=\"https:\/\/www.eisai.com\/\">\u30a8\u30fc\u30b6\u30a4<\/a> \u304c\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u958b\u767a\u3068\u627f\u8a8d\u7533\u8acb\u3092\u884c\u3044\u307e\u3059\u3002\u4e00\u65b9\u3001\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u306f\u3001\u7c73\u56fd\u306b\u304a\u3051\u308b\u672c\u6cbb\u7642\u85ac\u306e\u5171\u540c\u8ca9\u58f2\u3068\u30d7\u30ed\u30e2\u30fc\u30b7\u30e7\u30f3\u3092\u884c\u3044\u307e\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>Eisai Co., Ltd. and Biogen Inc. LEQEMBI\u00ae IQLIK\u2122 (lecanemab-irmb) is now available in the U.S. It\u2019s a subcutaneous injection for treating early Alzheimer&#8217;s disease (AD). It includes people with mild cognitive impairment (MCI) and mild dementia. This new option comes after an 18-month IV treatment with LEQEMBI. Patients can choose to keep their IV doses every four weeks or switch to a weekly 360 mg subcutaneous injection. They can use the LEQEMBI IQLIK autoinjector for this. Eisai and Biogen have launched the LEQEMBI Companion\u2122 program to support patients during treatment. This program offers various resources, such as: Educational support from nurse educators A welcome kit for care partners A digital [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":22173,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[872,7394,1715,8340,424],"ppma_author":[572],"class_list":{"0":"post-22172","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-health-tech","9":"category-japan","10":"category-news","11":"category-pharma","12":"category-regional","13":"tag-alzheimer-disease","14":"tag-biogen","15":"tag-eisai","16":"tag-leqembi-iqlik","17":"tag-pharma"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eisai &amp; Biogen Launch LEQEMBI IQLIK Injection<\/title>\n<meta name=\"description\" content=\"Eisai and Biogen launch LEQEMBI\u00ae IQLIK\u2122, a weekly subcutaneous injection for early Alzheimer\u2019s, offering an alternative to IV treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eisai &amp; Biogen Launch LEQEMBI IQLIK Injection\" \/>\n<meta property=\"og:description\" content=\"Eisai and Biogen launch LEQEMBI\u00ae IQLIK\u2122, a weekly subcutaneous injection for early Alzheimer\u2019s, offering an alternative to IV treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T12:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Eisai-and-Biogen-Announce-U.S.-Availability-of-LEQEMBI\u00ae-IQLIK\u2122-lecanemab-irmb-Subcutaneous-Injection-Maintenance-Dose-for-Treatment-of-Early-Alzheimers-Disease.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u3001LEQEMBI IQLIK\u6ce8\u5c04\u5264\u3092\u65b0\u767a\u58f2","description":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u793e\u3001\u65e9\u671f\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u8a8d\u77e5\u75c7\u6cbb\u7642\u5264\u300cLEQEMBI\u00ae IQLIK\u2122\u300d\u3092\u90311\u56de\u76ae\u4e0b\u6ce8\u88fd\u5264\u3068\u3057\u3066\u767a\u58f2\u3001\u70b9\u6ef4\u9759\u6ce8\u306b\u4ee3\u308f\u308b\u6cbb\u7642\u6cd5\u3092\u63d0\u4f9b.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/","og_locale":"ja_JP","og_type":"article","og_title":"Eisai & Biogen Launch LEQEMBI IQLIK Injection","og_description":"Eisai and Biogen launch LEQEMBI\u00ae IQLIK\u2122, a weekly subcutaneous injection for early Alzheimer\u2019s, offering an alternative to IV treatment.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/","og_site_name":"itbusinesstoday","article_published_time":"2025-10-07T12:33:15+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Eisai-and-Biogen-Announce-U.S.-Availability-of-LEQEMBI\u00ae-IQLIK\u2122-lecanemab-irmb-Subcutaneous-Injection-Maintenance-Dose-for-Treatment-of-Early-Alzheimers-Disease.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer","datePublished":"2025-10-07T12:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/"},"wordCount":330,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Eisai-and-Biogen-Announce-U.S.-Availability-of-LEQEMBI\u00ae-IQLIK\u2122-lecanemab-irmb-Subcutaneous-Injection-Maintenance-Dose-for-Treatment-of-Early-Alzheimers-Disease.webp","keywords":["Alzheimer disease","Biogen","Eisai","LEQEMBI IQLIK","Pharma"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/","name":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u3001LEQEMBI IQLIK\u6ce8\u5c04\u5264\u3092\u65b0\u767a\u58f2","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Eisai-and-Biogen-Announce-U.S.-Availability-of-LEQEMBI\u00ae-IQLIK\u2122-lecanemab-irmb-Subcutaneous-Injection-Maintenance-Dose-for-Treatment-of-Early-Alzheimers-Disease.webp","datePublished":"2025-10-07T12:33:15+00:00","description":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u793e\u3001\u65e9\u671f\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u8a8d\u77e5\u75c7\u6cbb\u7642\u5264\u300cLEQEMBI\u00ae IQLIK\u2122\u300d\u3092\u90311\u56de\u76ae\u4e0b\u6ce8\u88fd\u5264\u3068\u3057\u3066\u767a\u58f2\u3001\u70b9\u6ef4\u9759\u6ce8\u306b\u4ee3\u308f\u308b\u6cbb\u7642\u6cd5\u3092\u63d0\u4f9b.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Eisai-and-Biogen-Announce-U.S.-Availability-of-LEQEMBI\u00ae-IQLIK\u2122-lecanemab-irmb-Subcutaneous-Injection-Maintenance-Dose-for-Treatment-of-Early-Alzheimers-Disease.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Eisai-and-Biogen-Announce-U.S.-Availability-of-LEQEMBI\u00ae-IQLIK\u2122-lecanemab-irmb-Subcutaneous-Injection-Maintenance-Dose-for-Treatment-of-Early-Alzheimers-Disease.webp","width":1200,"height":800,"caption":"Eisai"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisai-and-biogen-introduce-leqembi-iqlik-for-alzheimer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=22172"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22172\/revisions"}],"predecessor-version":[{"id":22174,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22172\/revisions\/22174"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/22173"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=22172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=22172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=22172"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=22172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}